Infosys Collaborates with Telstra for AI-led Engineering Transformation
Set to accelerate innovation for Telstra and further enhance customer experience BENGALURU, India , May 16, 2024 /PRNewswire/ — Infosys (NSE: INFY), (BSE:... Read more.
iCIMS Delivers Next-Generation CRM Technology with Availability of AI-powered iCIMS Candidate Experience Management
The new solution was awarded “Best Emerging Technology” at the 2024 American Business Awards HOLMDEL, N.J., May 16, 2024 /PRNewswire/ — iCIMS,... Read more.
Desjardins Global Asset Management Opens the Market
TORONTO, May 16, 2024 /PRNewswire/ – Nicolas Richard, President and Chief Executive Officer, Desjardins Global Asset Management, Frédérick Tremblay, Managing... Read more.
CISCO REPORTS THIRD QUARTER EARNINGS
SAN JOSE, Calif., May 15, 2024 /PRNewswire/ — News Summary: $12.7 billion in revenue, down 13% year over year, in line with expectations and reflects our customers’... Read more.
Snail, Inc. Reports First Quarter 2024 Financial Results
CULVER CITY, Calif., May 15, 2024 /PRNewswire/ — Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent... Read more.
Fathom Congratulates Amanda Langford on Appointment to The SHRM Executive Network
CARY, N.C., May 15, 2024 /PRNewswire/ — Fathom Holdings, Inc. (Nasdaq: FTHM) (“Fathom” or the “Company”), a national, technology-driven,... Read more.
Illumina To Webcast Upcoming Investor Conference
SAN DIEGO, May 15, 2024 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:... Read more.
Lam Research Corporation Announces Participation at Upcoming Conferences
FREMONT, Calif., May 15, 2024 /PRNewswire/ — Lam Research Corp. (Nasdaq: LRCX) today announced that Tim Archer, President and Chief Executive Officer and Doug... Read more.
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
WALTHAM, Mass., May 15, 2024 /PRNewswire/ — Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline... Read more.
SOS Limited Reports 2023 Financial Results
Operating loss of $4.8 million compared to $215 million in 2022 Revenues declined from $260.0 million to $92.4 million driven by a decline in commodity revenues... Read more.